Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) - Global Forecast to 2026
Description
Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) - Global Forecast to 2026
The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests. On the other hand, stringent and time-consuming regulatory policies that significantly increase the product launch cycle may challenge market growth post their commercialization.
“The assays & kits accounted for the highest growth rate in the point-of-care molecular diagnostics market, by product & service, during the forecast period”
The point-of-care molecular diagnostics market is segmented into assays & kits, instruments & analyzers and software and services. The assays & kits segment accounted for the highest growth rate in the point-of-care molecular diagnostics market in 2020. The requirement assays & kits in large numbers compared to instruments is the main factor contributing to this segment's high growth rate. This segment's market growth can also be attributed to repeat purchases of assays & kits compared to instruments.
“Sexually transmitted diseases segment accounted for the highest CAGR”
Based on applications, the point-of-care molecular diagnostics market is segmented into respiratory diseases, sexually transmitted diseases, hospital-acquired infections, cancer, hepatitis, gastrointestinal disorders, and other applications. In 2020, the sexually transmitted diseases segment accounted for the highest growth rate. The increasing prevalence of CT/NG infections, HPV, HIV, and Trichomonas vaginalis and technological advancements are major factors driving the growth of this market segment.
“Hospitals & ICUs segment accounted for the highest CAGR”
Based on end users, the market is segmented into physicians’ offices, hospitals & ICUs, research institutes, and other end users. In 2020, the hospitals & ICUs segment accounted for the highest growth rate. This can be attributed to the increasing number of hospitals and high demand for diagnostic products in hospitals.
“North America: The fastest-growing region point-of-care molecular diagnostics market”
The global point-of-care molecular diagnostics market is segmented into North America, Europe, Asia Pacific and the Rest of the World. North America accounted for the largest share of the global point-of-care molecular diagnostics market. Factors such as the highly developed healthcare system in the US and Canada and the easy accessibility to technologically advanced instruments are driving the growth of the point-of-care molecular diagnostics market in this region.
The primary interviews conducted for this report can be categorized as follows:
By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
By Designation: C-level - 27%, D-level - 18%, and Others - 55%
By Region: North America - 51%, Europe - 21%, Asia Pacific - 18% and the Rest of the World – 10%
Lits of Companies Profiled in the Report:
Abbott Laboratories (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
bioMérieux SA (France)
Danaher Corporation (US)
Quidel Corporation (US)
QIAGEN N.V. (Netherlands)
Co-Diagnostics, Inc. (US)
Biocartis NV (Belgium)
Meridian Bioscience, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Lucira Health, Inc. (US)
Cue Health (US)
OpGen, Inc. (US)
Binx Health, Inc. (US)
Molbio Diagnostics Pct. Ltd. (India)
Genomadix (Canada)
Visby Medical, Inc. (US)
QuikPath PTE Ltd. (Singapore)
MD-Bio (US)
QuantuMDx Group Ltd. (UK)
Aidian Oy (Finland)
GeneSTAT Molecular Diagnostics, LLC (US).
Research Coverage:
This report provides a detailed picture of the global point-of-care molecular diagnostics market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall point-of-care molecular diagnostics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.
The global point-of-care molecular diagnostics market size is projected to reach USD 4.1 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious diseases and cancer, rising focus on decentralized diagnostics and increasing R&D funding, increasing awareness on the early detection of infectious diseases, and the increasing use of POC diagnostic tests. On the other hand, stringent and time-consuming regulatory policies that significantly increase the product launch cycle may challenge market growth post their commercialization.
“The assays & kits accounted for the highest growth rate in the point-of-care molecular diagnostics market, by product & service, during the forecast period”
The point-of-care molecular diagnostics market is segmented into assays & kits, instruments & analyzers and software and services. The assays & kits segment accounted for the highest growth rate in the point-of-care molecular diagnostics market in 2020. The requirement assays & kits in large numbers compared to instruments is the main factor contributing to this segment's high growth rate. This segment's market growth can also be attributed to repeat purchases of assays & kits compared to instruments.
“Sexually transmitted diseases segment accounted for the highest CAGR”
Based on applications, the point-of-care molecular diagnostics market is segmented into respiratory diseases, sexually transmitted diseases, hospital-acquired infections, cancer, hepatitis, gastrointestinal disorders, and other applications. In 2020, the sexually transmitted diseases segment accounted for the highest growth rate. The increasing prevalence of CT/NG infections, HPV, HIV, and Trichomonas vaginalis and technological advancements are major factors driving the growth of this market segment.
“Hospitals & ICUs segment accounted for the highest CAGR”
Based on end users, the market is segmented into physicians’ offices, hospitals & ICUs, research institutes, and other end users. In 2020, the hospitals & ICUs segment accounted for the highest growth rate. This can be attributed to the increasing number of hospitals and high demand for diagnostic products in hospitals.
“North America: The fastest-growing region point-of-care molecular diagnostics market”
The global point-of-care molecular diagnostics market is segmented into North America, Europe, Asia Pacific and the Rest of the World. North America accounted for the largest share of the global point-of-care molecular diagnostics market. Factors such as the highly developed healthcare system in the US and Canada and the easy accessibility to technologically advanced instruments are driving the growth of the point-of-care molecular diagnostics market in this region.
The primary interviews conducted for this report can be categorized as follows:
By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
By Designation: C-level - 27%, D-level - 18%, and Others - 55%
By Region: North America - 51%, Europe - 21%, Asia Pacific - 18% and the Rest of the World – 10%
Lits of Companies Profiled in the Report:
Abbott Laboratories (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
bioMérieux SA (France)
Danaher Corporation (US)
Quidel Corporation (US)
QIAGEN N.V. (Netherlands)
Co-Diagnostics, Inc. (US)
Biocartis NV (Belgium)
Meridian Bioscience, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Lucira Health, Inc. (US)
Cue Health (US)
OpGen, Inc. (US)
Binx Health, Inc. (US)
Molbio Diagnostics Pct. Ltd. (India)
Genomadix (Canada)
Visby Medical, Inc. (US)
QuikPath PTE Ltd. (Singapore)
MD-Bio (US)
QuantuMDx Group Ltd. (UK)
Aidian Oy (Finland)
GeneSTAT Molecular Diagnostics, LLC (US).
Research Coverage:
This report provides a detailed picture of the global point-of-care molecular diagnostics market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall point-of-care molecular diagnostics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.
Table of Contents
225 Pages
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- CURRENCY
- LIMITATIONS
- STAKEHOLDERS
- SUMMARY OF CHANGES
- RESEARCH DATA
- RESEARCH APPROACH
- MARKET SIZE ESTIMATION
- MARKET BREAKDOWN & DATA TRIANGULATION
- MARKET SHARE ANALYSIS
- ASSUMPTIONS FOR THE STUDY
- RISK ASSESSMENT
- GROWTH RATE ASSUMPTIONS
- COVID-19 HEALTH ASSESSMENT
- COVID-19 ECONOMIC ASSESSMENT
- ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
- ASSESSMENT OF THE IMPACT OF COVID-19 ON THE POINT-OFCARE MOLECULAR DIAGNOSTICS MARKET
- EXECUTIVE SUMMARY
- POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET OVERVIEW
- POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE, BY PRODUCT & SERVICE, 2021 VS. 2026
- POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE, BY TECHNOLOGY, 2021 VS. 2026
- POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE, BY APPLICATION, 2021 VS. 2026
- POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE, BY END USER, 2021 VS. 2026
- POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- INTRODUCTION
- MARKET DYNAMICS
- IMPACT OF COVID-19 ON THE POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET
- PRICING ANALYSIS
- PATENT ANALYSIS
- TRADE ANALYSIS
- VALUE CHAIN ANALYSIS
- SUPPLY CHAIN ANALYSIS
- ECOSYSTEM ANALYSIS
- PORTER'S FIVE FORCES ANALYSIS
- PESTLE ANALYSIS
- REGULATORY LANDSCAPE
- TECHNOLOGY ANALYSIS
- DISRUPTIVE TECHNOLOGIES IN THE POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET
- INTRODUCTION
- ASSAYS & KITS
- INSTRUMENTS & ANALYZERS
- SOFTWARE & SERVICES
- INTRODUCTION
- RT-PCR
- INAAT
- OTHER TECHNOLOGIES
- INTRODUCTION
- RESPIRATORY DISEASES
- SEXUALLY TRANSMITTED DISEASES
- HOSPITAL-ACQUIRED INFECTIONS
- CANCER
- HEPATITIS
- GASTROINTESTINAL DISORDERS
- OTHER APPLICATIONS
- INTRODUCTION
- PHYSICIANS' OFFICES
- HOSPITALS & ICUS
- RESEARCH INSTITUTES
- OTHER END USERS
- INTRODUCTION
- NORTH AMERICA
- EUROPE
- ASIA PACIFIC
- REST OF THE WORLD
- OVERVIEW
- KEY PLAYER STRATEGIES/RIGHT TO WIN
- REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
- MARKET SHARE ANALYSIS
- COMPANY EVALUATION QUADRANT
- COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2020)
- COMPETITIVE BENCHMARKING
- COMPETITIVE SCENARIO
- KEY PLAYERS
- OTHER PLAYERS
- DISCUSSION GUIDE
- KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- AVAILABLE CUSTOMIZATIONS
- RELATED REPORTS
- AUTHOR DETAILS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
